| Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes EUGenMed, Cardiovascular Clinical Study Group, V Regitz-Zagrosek, ... European heart journal 37 (1), 24-34, 2016 | 753 | 2016 |
| A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and … M Lorenz, S Wessler, E Follmann, W Michaelis, T Düsterhöft, ... Journal of Biological Chemistry 279 (7), 6190-6195, 2004 | 446 | 2004 |
| Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases N Jochmann, K Stangl, E Garbe, G Baumann, V Stangl European heart journal 26 (16), 1585-1595, 2005 | 434 | 2005 |
| Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study D Hilfiker-Kleiner, A Haghikia, D Berliner, J Vogel-Claussen, J Schwab, ... European heart journal 38 (35), 2671-2679, 2017 | 362 | 2017 |
| Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study SB Felix, A Staudt, WV Dörffel, V Stangl, K Merkel, M Pohl, WD Döcke, ... Journal of the American College of Cardiology 35 (6), 1590-1598, 2000 | 362 | 2000 |
| The role of tea and tea flavonoids in cardiovascular health V Stangl, M Lorenz, K Stangl Molecular nutrition & food research 50 (2), 218-228, 2006 | 339 | 2006 |
| Molecular targets of tea polyphenols in the cardiovascular system V Stangl, H Dreger, K Stangl, M Lorenz Cardiovascular research 73 (2), 348-358, 2007 | 316 | 2007 |
| Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution A Staudt, F Schäper, V Stangl, A Plagemann, M Böhm, K Merkel, ... Circulation 103 (22), 2681-2686, 2001 | 260 | 2001 |
| Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection H Dreger, K Westphal, A Weller, G Baumann, V Stangl, S Meiners, ... Cardiovascular research 83 (2), 354-361, 2009 | 257 | 2009 |
| Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption SB Felix, A Staudt, M Landsberger, Y Grosse, V Stangl, T Spielhagen, ... Journal of the American College of Cardiology 39 (4), 646-652, 2002 | 253 | 2002 |
| Coronary atherogenic risk factors in women V Stangl, G Baumann, K Stangl European Heart Journal 23 (22), 1738-1752, 2002 | 244 | 2002 |
| The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells A Ludwig, M Lorenz, N Grimbo, F Steinle, S Meiners, C Bartsch, K Stangl, ... Biochemical and biophysical research communications 316 (3), 659-665, 2004 | 239 | 2004 |
| Addition of milk prevents vascular protective effects of tea M Lorenz, N Jochmann, A von Krosigk, P Martus, G Baumann, K Stangl, ... European heart journal 28 (2), 219-223, 2007 | 237 | 2007 |
| Maternal heart disease and pregnancy outcome: a single‐centre experience V Stangl, J Schad, G Gossing, A Borges, G Baumann, K Stangl European journal of heart failure 10 (9), 855-860, 2008 | 169 | 2008 |
| The efficacy of black tea in ameliorating endothelial function is equivalent to that of green tea N Jochmann, M Lorenz, A von Krosigk, P Martus, V Böhm, G Baumann, ... British Journal of Nutrition 99 (4), 863-868, 2008 | 165 | 2008 |
| Proteasome inhibitors: poisons and remedies S Meiners, A Ludwig, V Stangl, K Stangl Medicinal research reviews 28 (2), 309-327, 2008 | 162 | 2008 |
| Green and black tea are equally potent stimuli of NO production and vasodilation: new insights into tea ingredients involved M Lorenz, J Urban, U Engelhardt, G Baumann, K Stangl, V Stangl Basic research in cardiology 104, 100-110, 2009 | 161 | 2009 |
| Left atrial function in preclinical diastolic dysfunction: two-dimensional speckle-tracking echocardiography–derived results from the BEFRI trial A Brecht, S Oertelt-Prigione, U Seeland, M Ruecke, R Haettasch, ... Journal of the American Society of Echocardiography 29 (8), 750-758, 2016 | 159 | 2016 |
| Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience M Laule, V Stangl, W Sanad, A Lembcke, G Baumann, K Stangl Journal of the American College of Cardiology 61 (18), 1929-1931, 2013 | 147 | 2013 |
| Negative inotropic mediators released from the heart after myocardial ischaemia–reperfusion V Stangl, G Baumann, K Stangl, SB Felix Cardiovascular research 53 (1), 12-30, 2002 | 147 | 2002 |
